-
PPARγ Activation Rebalances Macrophages in DSS Colitis
2026-08-15
This study identifies PPARγ activation as a regulator of M1/M2 macrophage polarization in dextran sulfate sodium-induced inflammatory bowel disease. Using RAW264.7 cells and a mouse colitis model, the authors connect reduced STAT-1 phosphorylation and enhanced STAT-6 phosphorylation with improved intestinal barrier integrity and clinical disease features.
-
N1-Methyl-Pseudouridine-5'-Triphosphate Workflow
2026-08-14
Build more stable, translation-ready RNA with N1-Methyl-Pseudouridine-5'-Triphosphate while preserving a clear path from in vitro transcription to cell-based testing. The workflow also shows how junction-resolved assays inspired by R2 retrotransposon research can separate RNA quality effects from downstream DNA-repair outcomes.
-
Plk1 Control of Mitotic Checkpoint Disassembly
2026-08-14
The reference study identifies Polo-like kinase 1 (Plk1) as a negative regulator of p31comet-dependent mitotic checkpoint complex disassembly. Its evidence shows that Plk1 phosphorylates p31comet at S102, suppressing cooperation with TRIP13 and helping prevent premature cycling between checkpoint assembly and disassembly.
-
Polymyxin B Sulfate Workflows for Infection Research
2026-08-13
Build reproducible Gram-negative infection, LPS-perturbation, and dendritic-cell experiments with Polymyxin B sulfate. This guide separates membrane-disruptive antimicrobial effects from immune-signaling artifacts while translating recent microbiome–immunotherapy findings into practical assay controls.
-
Fucoidan Workflows for Cancer and Membrane Biology
2026-08-13
Fucoidan combines cancer-cell pathway analysis with immune and angiogenesis readouts, making it useful for multi-layered preclinical workflows rather than single-endpoint screening. This guide shows how to prepare the compound, build dose-response experiments, and use herpesvirus membrane-fusion findings to improve assay design without overstating Fucoidan’s antiviral mechanism.
-
Dimetridazole Workflows for Antimicrobial Research
2026-08-12
Dimetridazole supports more than a conventional antimicrobial screen: it can be evaluated as a quorum sensing inhibitor, biofilm-disrupting research tool, combination partner, and electrochemical sensor analyte. This workflow-focused guide connects culture assays, infection model research, and molecularly imprinted detection while emphasizing controls, matrix effects, and troubleshooting.
-
S-Adenosylhomocysteine in Neural Differentiation Assays
2026-08-12
Use S-Adenosylhomocysteine to test whether methylation-cycle pressure contributes to radiation-associated changes in neural differentiation, rather than treating neurite outgrowth as a pathway-specific endpoint. This workflow combines SAM/SAH ratio modulation with PI3K-STAT3-mGluR1 readouts, rescue controls, and practical handling guidance.
-
EPZ-6438: A Practical EZH2 Inhibitor Workflow
2026-08-11
EPZ-6438 enables selective interrogation of EZH2-dependent H3K27me3 repression in lymphoma, malignant rhabdoid tumor, and melanoma workflows. Its strongest use-case is a time-resolved pharmacodynamic assay that connects epigenetic mark loss with genotype-specific viability and rational combination responses.
-
Haloprogin: Evidence from a 1970 Topical Study
2026-08-11
Harrison and colleagues established Haloprogin as a topical agent with dermatophyte activity comparable to tolnaftate, while demonstrating additional activity against Candida species and selected Gram-positive bacteria. The study is notable for combining serial-dilution testing, fungicidal readouts, serum-effect analysis, and guinea pig infection models to connect laboratory potency with topical efficacy.
-
Candida krusei Phases Trigger Distinct BMEC Apoptosis
2026-08-10
The reference study shows that Candida krusei yeast and hypha phases both induce apoptosis in bovine mammary epithelial cells, but they preferentially engage different signaling routes. Its phase-resolved co-culture design connects fungal morphology with mitochondrial, death receptor, TLR, and MAPK-associated responses, providing a useful framework for interpreting fungal mastitis mechanisms.
-
Sulfaphenazole Restores Perfusion in Skin Injury
2026-08-09
The reference study shows that Sulfaphenazole can reduce pressure- and thermal-injury severity in mice by rapidly restoring tissue perfusion after ischemia–reperfusion. Its importance lies in linking CYP2C inhibition, oxidative stress reduction, improved wound repair, and enhanced antibacterial macrophage activity in a single preclinical framework.
-
VX-702: Selective p38α MAPK Inhibitor
2026-08-08
VX-702 is an ATP-competitive p38α MAPK inhibitor that targets MAPK14 with a reported IC50 range of 4–20 nM. Product data support applications in cytokine suppression, platelet storage research, collagen-induced arthritis, and myocardial ischemia-reperfusion injury, while class-level phosphatase findings require careful separation from compound-specific evidence.
-
Hepatic sEH, Nrf2, and Osteoporosis
2026-08-07
A 2025 study identifies a liver–bone axis in which hepatic soluble epoxide hydrolase alters circulating 14,15-EET and 14,15-DHET, suppresses Nrf2 signaling, and promotes osteoclastogenesis. Its combination of patient samples, ovariectomy-induced osteoporosis, liver-specific manipulation, cell experiments, and transcriptomics provides a mechanistic framework for studying redox imbalance in bone disease.
-
Ribonuclease R (20 U/μL): Precision Circular RNA Enrichment
2026-08-07
Leverage the unique specificity of Ribonuclease R (20 U/μL) to distinguish and enrich circular RNAs from complex samples, enabling advanced RNA structure and inflammation studies. This guide details optimized protocols, troubleshooting strategies, and insight from recent pulpitis research to empower reproducible, high-fidelity circRNA analysis.
-
Deferoxamine Mesylate: Iron-Chelating Agent in Hypoxia & Str
2026-08-06
Deferoxamine mesylate empowers researchers to precisely manipulate iron homeostasis, model hypoxic pathways, and protect tissues from oxidative damage. This guide translates bench-proven workflows and the latest discoveries—such as TCF25-regulated lysosomal cell death—into actionable protocols and troubleshooting strategies.